MannKind (MNKD) – PRNewswire
-
MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population
-
United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021
-
United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021
-
NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory Conditions
-
MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil) Based On The Technosphere® Platform
-
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story And Race Go-Karts With Local Youth On Wednesday, August 4th
-
Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use Both Afrezza® And Continuous Glucose Monitoring Devices Beginning July 18
-
MannKind Presents Two Posters At American Diabetes Association's Virtual 81st Scientific Sessions, June 25-29
-
MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Application Acceptance From The FDA
-
United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review
-
MannKind Announces Data Presentation At 14th International Conference On Advanced Technologies & Treatments For Diabetes (ATTD 2021) To Be Held Virtually June 2-5
-
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story And Race Go-karts With Local Youth On Tuesday, May 25th
-
MannKind Announces Partnership With Type 1 Diabetes IndyCar Driver Conor Daly
-
United Therapeutics Announces Submission of Tyvaso DPI™ New Drug Application to FDA
-
Vertice launches THYQUIDITY™ (levothyroxine sodium) Oral Solution
Back to MNKD Stock Lookup
